Pharmacokinetics and Safety of Cefazolin 2g in DUPLEX
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate the safety and pharmacokinetics of Cefazolin 2g
for Injection USP and Dextrose Injection USP in the DUPLEX® Drug Delivery System to Cefazolin
1.5g for Injection USP and Dextrose Injection USP in daily doses of 6g in healthy adult
subjects for 11 days of administration.